Division of Infectious Diseases
-
August 12, 2021
Certain drug exposures correlate with reduced COVID severity: study
Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis. -
August 11, 2021
Aronoff departing VUMC to become chair of the Department of Medicine at Indiana University School of Medicine
David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine. -
July 27, 2021
Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study
A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020. -
July 22, 2021
Influenza network sizes up COVID
Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients. -
June 21, 2021
Two VUMC physician-scientists win Burroughs Wellcome Fund Career Awards
Two physician-scientist Instructors in Medicine at Vanderbilt University Medical Center (VUMC) — Jeeyeon Cha, MD, PhD, and Celestine Wanjalla, MD, PhD — are among 12 recipients of the 2021 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists. -
June 16, 2021
New Clinician Spotlight: Titus Daniels
Titus Daniels, MD, MPH, MMHC, has returned to Vanderbilt University Medical Center; he was previously on the faculty from 2007 to 2017. -
April 29, 2021
VUMC team screens high school for SARS-CoV-2 asymptomatic infections
Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.